<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 03 Jun 2021 12:16:50 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>图解政策 | “数”说十三五 药品安全这五年</title><link>https://mp.weixin.qq.com/s/cXLl0Wy_UQok-ebBrEjtVQ</link><description></description><content:encoded><![CDATA[图解政策 | “数”说十三五 药品安全这五年]]></content:encoded><pubDate>Wed, 02 Jun 2021 23:51:56 +0800</pubDate></item><item><title>ADC管线布局哪家强，且往第一三共瞧</title><link>https://mp.weixin.qq.com/s/gYMydk9RJi_rFj8SISvbQg</link><description></description><content:encoded><![CDATA[ADC管线布局哪家强，且往第一三共瞧]]></content:encoded><pubDate>Wed, 02 Jun 2021 23:51:56 +0800</pubDate></item><item><title>中国科兴新冠疫苗获世卫组织紧急使用认证</title><link>https://mp.weixin.qq.com/s/l6fhB9A2TuTLtj0jFjFz9w</link><description></description><content:encoded><![CDATA[中国科兴新冠疫苗获世卫组织紧急使用认证]]></content:encoded><pubDate>Wed, 02 Jun 2021 23:51:56 +0800</pubDate></item><item><title>6.1节大礼包，CDE开通“儿童用药专栏”，儿童用药迎来新机遇！多指导原则！</title><link>https://mp.weixin.qq.com/s/IfSF0QOKr54Vhila8Dyhlg</link><description></description><content:encoded><![CDATA[6.1节大礼包，CDE开通“儿童用药专栏”，儿童用药迎来新机遇！多指导原则！]]></content:encoded><pubDate>Tue, 01 Jun 2021 20:53:47 +0800</pubDate></item><item><title>重磅：NMPA发布关于贯彻实施《医疗器械监督管理条例》有关事项的公告</title><link>https://mp.weixin.qq.com/s/Tf25XJXZB2F6f2TT4TE0ZA</link><description></description><content:encoded><![CDATA[重磅：NMPA发布关于贯彻实施《医疗器械监督管理条例》有关事项的公告]]></content:encoded><pubDate>Tue, 01 Jun 2021 20:53:47 +0800</pubDate></item><item><title>胆管癌新药！泛FGFR激酶抑制剂derazantinib治疗肝内胆管癌(iCCA)：疾病控制率74.8%!</title><link>https://mp.weixin.qq.com/s/S606BKtjqWWpwF5fv8nD8Q</link><description></description><content:encoded><![CDATA[胆管癌新药！泛FGFR激酶抑制剂derazantinib治疗肝内胆管癌(iCCA)：疾病控制率74.8%!]]></content:encoded><pubDate>Tue, 01 Jun 2021 20:53:47 +0800</pubDate></item><item><title>什么是新药的“有条件批准上市”？</title><link>https://mp.weixin.qq.com/s/lC1FCQ5z4ezCysriATpQhg</link><description></description><content:encoded><![CDATA[什么是新药的“有条件批准上市”？]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>CDE部长杨志敏等专家解答，药品申报注册18 问及注册生产现场检查流程</title><link>https://mp.weixin.qq.com/s/KnXMR-_udPZZLeTiVntCog</link><description></description><content:encoded><![CDATA[CDE部长杨志敏等专家解答，药品申报注册18 问及注册生产现场检查流程]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>首个国产一线肝细胞癌靶向药物即将获批上市</title><link>https://mp.weixin.qq.com/s/TnPeagA95q81wBZrwpJTYg</link><description></description><content:encoded><![CDATA[首个国产一线肝细胞癌靶向药物即将获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>中英文 ICH-Q8,Q9,Q10 课件ppt</title><link>https://mp.weixin.qq.com/s/-U9t2Z3hXe4bYSmfzE2CDg</link><description></description><content:encoded><![CDATA[中英文 ICH-Q8,Q9,Q10 课件ppt]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>严重副作用不同疾病的对应手册（面向患者·公众）（63）-惊厥、癫痫</title><link>https://mp.weixin.qq.com/s/Ysk7dK2nyt9X-IPgPtNipA</link><description></description><content:encoded><![CDATA[严重副作用不同疾病的对应手册（面向患者·公众）（63）-惊厥、癫痫]]></content:encoded><pubDate>Sun, 30 May 2021 21:15:54 +0800</pubDate></item><item><title>中检院：药品注册检验送检须知</title><link>https://mp.weixin.qq.com/s/fyLcRZo7aCDSLGDFmx2Fkw</link><description></description><content:encoded><![CDATA[中检院：药品注册检验送检须知]]></content:encoded><pubDate>Sun, 30 May 2021 21:15:54 +0800</pubDate></item><item><title>CDE专家解析《药品注册管理办法》</title><link>https://mp.weixin.qq.com/s/_6n0v8Bv18dg5THTjI848Q</link><description></description><content:encoded><![CDATA[CDE专家解析《药品注册管理办法》]]></content:encoded><pubDate>Sun, 30 May 2021 21:15:54 +0800</pubDate></item><item><title>《药品检查管理办法（试行）》发布</title><link>https://mp.weixin.qq.com/s/0isRMc8YAmr4BV4h-hJsXA</link><description></description><content:encoded><![CDATA[《药品检查管理办法（试行）》发布]]></content:encoded><pubDate>Sat, 29 May 2021 19:47:30 +0800</pubDate></item><item><title>PD-1/PD-L1 抑制剂的剂量选择与优化</title><link>https://mp.weixin.qq.com/s/FJd_xerZOaB5AR189GT6NA</link><description></description><content:encoded><![CDATA[PD-1/PD-L1 抑制剂的剂量选择与优化]]></content:encoded><pubDate>Sat, 29 May 2021 19:47:30 +0800</pubDate></item><item><title>一文理清！最全肿瘤标志物解读！</title><link>https://mp.weixin.qq.com/s/_swb6AeS2GUlvbuqFXD3_g</link><description></description><content:encoded><![CDATA[一文理清！最全肿瘤标志物解读！]]></content:encoded><pubDate>Sat, 29 May 2021 19:47:30 +0800</pubDate></item><item><title>重磅！全球首个新冠灭活疫苗Ⅲ期临床数据正式发表</title><link>https://mp.weixin.qq.com/s/uXCJSJLKobz61_gvzHeJiw</link><description></description><content:encoded><![CDATA[重磅！全球首个新冠灭活疫苗Ⅲ期临床数据正式发表]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>NMPA发布：执业药师电子注册证来了，长这样</title><link>https://mp.weixin.qq.com/s/Uo4OF7ezxahLDM3vH536FQ</link><description></description><content:encoded><![CDATA[NMPA发布：执业药师电子注册证来了，长这样]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>深度解读：后新冠时代，疫苗研发未来可期（内含福利）</title><link>https://mp.weixin.qq.com/s/M0XL03g1Ul0B44HaRvKFJQ</link><description></description><content:encoded><![CDATA[深度解读：后新冠时代，疫苗研发未来可期（内含福利）]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>药典委关于2020年版药典相关问题的解读（一）</title><link>https://mp.weixin.qq.com/s/fj8quovXI3SAs2Zk3Suzzg</link><description></description><content:encoded><![CDATA[药典委关于2020年版药典相关问题的解读（一）]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item></channel></rss>